Glass Industry News

Ongoing Merger Clearance for deal between Bormioli Pharma and R&G

, Bormioli Pharma S.p.A.

Bormioli Pharma S.p.A. (“Bormioli Pharma”), a Triton Fund IV company announced that HIL-INVENT GmbH. (“HIL-INVENT”), as a majority shareholder, and a newly incorporated German vehicle wholly-owned by Bormioli Pharma (“Remus BidCo”) entered into a binding agreement for the acquisition of R&G Beteiligungs GmbH (“R&G”).

R&G is active in the business of plastic and glass primary packaging which are mainly used in the pharmaceutical industry. R&G employees approximately 270 people and operates through two plants in Schleusingen and Altenfeld (Germany). In the fiscal year 2018 R&G registered a turnover of Euro 25.6 m and an EBITDA equal to Euro 4.1 m (representing 16.0% margin).

Through this acquisition Bormioli Pharma reinforces its presence in the German and Northern European markets, expands its current product range with complementary products and strengthens its manufacturing footprint and industrial competences.

Closing of the transaction is planned for the fourth quarter of 2019 and is subject to the obtainment of the merger clearance by German competent authorities provided that no adverse circumstances which may materially affect R&G business and assets will occur in the meantime.

The acquisition will be financed through an acquisition financing extended by certain financial institutions to Bormioli Pharma S.p.A. and through the reinvestment by HIL-INVENT into Blitz LuxCo S.à.r.l., the sole shareholder of Bormioli Pharma, becoming a minority shareholder with a stake of 5.3%. Leverage Ratio pre-synergies, calculated as of 30th June 2019, will remain at 5.1x.

About Bormioli

Bormioli Pharma operates in close partnership with the pharmaceutical industry and with all the businesses that are engineering the future of healthcare. As a world-renowned player in the packaging industry, the company serves the pharmaceutical and biopharmaceutical market with integrated glass and plastic containers, closures, and packaging accessories using state-of-the-art materials and technologies. Each product is a unique combination of rigorous studies, cutting-edge technology, extreme testing, advanced industrial processes, and the finest materials. Bormioli Pharma has a global presence in 90 countries, with 900 employees and 5 plants in Europe specialized in the manufacturing of glass and plastic packaging for pharmaceutical, generics, and biotech companies, and CMOs. Every year the company produces 5 billion pieces with around 230 million euros in annual sales. As a partner to the pharmaceutical industry, Bormioli Pharma invests and innovates with one goal in mind: improving people’s lives.

For further information: www.bormiolipharma.com

 

Ongoing merger clearance started on 16.9.2019 under B3-145/19
Company:
Bormioli Pharma S.p.A., Mailand (Italien); purchase of shares and sole control in R & G Beteiligungs GmbH, Schleusingen (D);

Markets:
glass and plastic packaging for pharmaceutical industry

Company seat in :
Thüringen/Thuringia

, © Bormioli Pharma S.p.A.

Материал новостей на Сайте - авторское право и принадлежит Компании или третьему лицу, поставщику новостей , и все права сохранены. Любой Пользователь, который получает доступ к такому материалу, может делать это только в целях собственного использования, и использование такого материала - риск для самого Пользователя. Перераспределение или другая коммерческая эксплуатация такого материала новостей явно запрещены. Где такой материал новостей обеспечен третьим лицом, каждый Пользователь соглашается наблюдать и быть связанным определенными условиями использования, относящимися к такому материалу новостей. Мы не представляем или подтверждаем точность, или надежность любой информации содержащейся в любых новостях или внешних веб-сайтах, упомянутых в новостях.

Если содержание или оформление этих станиц нарушает права третьих лиц или положения закона, тогда мы просим о соответствующем уведомлении без необходимых издержек. Я ручаюсь, что по праву вызванное недовольство место в тексте будет незамедлительно удалено, не требуя подключения поверенного лица с Вашей стороны. Однако вызванные Вами расходы без преждевременного установления конакта будут нами в полной мере отклонены и при необходимости мы подадим встречную жалобу касательно нарушения вышеназванных положений.



Info Grid

Glass studies

Updated worldwide glass study 2024

plants.glassglobal.com

Updated hollow glass study 2024

Request more information

Updated float glass study 2024

Request more information

Further glass market studies

Request more information

Профиль компании



Updated worldwide glass market study 2024 available now for flat, container glass and tableware

We have updated our international studies on flat glass, container glass and tableware for 2024.

This unique software provides a global overview about glass producers and technical details. Easy to use and clear tables summarize information and data about glass makers such as: Glass types: flat glass, container glass, tableware, production capacities in regions and countries, number of furnaces, furnace types, year of construction, glass types and sub-types, products, project information, special news and downloads.

Further databases supplying demoscopic data and import and export data complete the market survey. Based on these data, prepare individual country profiles with information about local production capacities, local market sizes and expected demand in the future.

Request your offer via plants.glassglobal.com.

Updated container glass study 2024

X

Updated float glass study 2024

X

Further glass studies and reports 2024

X